Results 111 to 120 of about 11,634 (196)

Randomised comparison of femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: results of the FARMI Trial [PDF]

, 2007
Camille Brasselet, S Tassan, Pierre Nazeyrollas, M. Hamon, David C. Metz   +4 more
openalex   +1 more source

Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials [PDF]

, 2000
A. Michael Lincoff, LeRoy LeNarz, George J. Despotis, Peter K. Smith, Joan E. Booth, Russell Raymond, Shelly Sapp, Catherine F. Cabot, James E. Tcheng, Robert M. Califf, Mark B. Effron, Eric J. Topol   +11 more
openalex   +1 more source

Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction [PDF]

, 2002
Gregg W. Stone, Cindy L. Grines, David A. Cox, Eulogio Garcı́a, James E. Tcheng, John J. Griffin, Giulio Guagliumi, Thomas Stuckey, Mark Turco, John D. Carroll, Barry D. Rutherford, Alexandra J. Lansky   +11 more
openalex   +1 more source

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel or both?

Vascular Health and Risk Management, 2006
Matthew A Silva1, Jennifer L Donovan1,3, Pritesh J Gandhi2, Gregory A Volturo31Massachusetts College of Pharmacy and Health Sciences, Department of Pharmacy Practice, Worcester, MA, USA; 2Alexion Pharmaceuticals, Inc., Cheshire, CT, USA; 3UMass Memorial ...
Matthew A Silva, Jennifer L Donovan, Pritesh J Gandhi, Gregory A Volturo   +3 more
doaj  

Disaggregation of In Vitro Preformed Platelet-Rich Clots by Abciximab Increases Fibrin Exposure and Promotes Fibrinolysis [PDF]

, 2001
J.P. Collet, Gilles Montalescot, Claude Lesty, J. Soria, Z. Mishal, Daniel Thomas, Claudine Soria   +6 more
openalex   +1 more source

Importance of Complex Additional Stenosis After Primary Angioplasty for Acute Myocardial Infarction in Medium-Term Prognosis [PDF]

, 2004
Introdução: Existe alguma controvérsia respeitante ao tipo de revascularização a efectuar no contexto de angioplastia (PCI) primária no enfarte agudo do miocárdio (EAM).
Cruz Ferreira, R, Feliciano, J, Ferreira, ML, Fiarresga, A, Gonçalves, JM, Quininha, J, Timóteo, AT   +6 more
core  

CD2: ABCIXIMAB IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY: A MULTICENTER OBSERVATIONAL STUDY

, 1999
Vlasses Ph, C Chen, Harlan Krumholz, Douglas Cocks, David M. McGee, D. B. Morton   +5 more
openalex   +1 more source

Correction: Cost-Effectiveness Analysis of Abciximab: A Canadian Hospital Perspective [PDF]

, 1998

openalex   +1 more source

Advances in emerging therapies 2008 [PDF]

, 2009
Higgins, P., Lees, K.R.
core   +1 more source

Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos. The IIb/IIIa platelet receptor inhibitors in the acute coronary syndromes.

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2001
Los inhibidores de los receptores IIb/IIIa, un nuevo grupo de antiagregantes plaquetarios, son potentes bloqueadores del receptor que media la agregación plaquetaria y de ese modo bloquean la vía final común de la formación del trombo plaquetario.
Fidel Manuel Cáceres Lóriga, Horacio Pérez López   +1 more
doaj